1. Home
  2. SD vs NNNN Comparison

SD vs NNNN Comparison

Compare SD & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SandRidge Energy Inc.

SD

SandRidge Energy Inc.

HOLD

Current Price

$13.92

Market Cap

502.8M

Sector

Energy

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$10.12

Market Cap

417.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SD
NNNN
Founded
2006
2021
Country
United States
Germany
Employees
N/A
27
Industry
Oil & Gas Production
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
502.8M
417.8M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
SD
NNNN
Price
$13.92
$10.12
Analyst Decision
Strong Sell
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
246.0K
33.6K
Earning Date
05-05-2026
04-07-2026
Dividend Yield
3.07%
N/A
EPS Growth
12.43
N/A
EPS
0.50
N/A
Revenue
N/A
N/A
Revenue This Year
$12.65
N/A
Revenue Next Year
$1.75
N/A
P/E Ratio
$27.20
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$9.89
$8.30
52 Week High
$18.45
$54.90

Technical Indicators

Market Signals
Indicator
SD
NNNN
Relative Strength Index (RSI) 48.02 37.56
Support Level $13.26 $8.30
Resistance Level $13.99 $29.98
Average True Range (ATR) 0.29 1.31
MACD 0.03 0.58
Stochastic Oscillator 42.62 33.89

Price Performance

Historical Comparison
SD
NNNN

About SD SandRidge Energy Inc.

SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. The company's primary areas of operation are the Mid-Continent in Oklahoma and Kansas.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: